Clinical Impact of Glycans in Platelet and Megakaryocyte Biology

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2022 Jan 11

PMID 35015813

Authors

Herve Falet

Leonardo Rivadeneyra

Karin M Hoffmeister

Affiliations

Soon will be listed here.

Abstract

Humans produce and remove 1011 platelets daily to maintain a steady-state platelet count. The tight regulation of platelet production and removal from the blood circulation prevents anomalies in both processes from resulting in reduced or increased platelet count, often associated with the risk of bleeding or overt thrombus formation, respectively. This review focuses on the role of glycans, also known as carbohydrates or oligosaccharides, including N- and O-glycans, proteoglycans, and glycosaminoglycans, in human and mouse platelet and megakaryocyte physiology. Based on recent clinical observations and mouse models, we focused on the pathologic aspects of glycan biosynthesis and degradation and their effects on platelet numbers and megakaryocyte function.

Citing Articles

ABO blood groups and galectins: Implications in transfusion medicine and innate immunity.

Arthur C, Hollenhorst M, Wu S, Jajosky R, Nakahara H, Jan H Semin Immunol. 2024; 74-75:101892.

PMID: 39405833 PMC: 11808837. DOI: 10.1016/j.smim.2024.101892.

Elevating TPO production up a Notch.

Falet H, Hoffmeister K Blood. 2024; 143(26):2684-2686.

PMID: 38935361 PMC: 11251204. DOI: 10.1182/blood.2024024907.

The common variable immunodeficiency IgM repertoire narrowly recognizes erythrocyte and platelet glycans.

Le Coz C, Trofa M, Butler D, Yoon S, Tian T, Reid W J Allergy Clin Immunol. 2024; 154(3):778-791.e9.

PMID: 38692308 PMC: 11380600. DOI: 10.1016/j.jaci.2024.04.018.

Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis.

Piszczatowski R, Bulow H, Steidl U Blood. 2024; 143(25):2571-2587.

PMID: 38639475 PMC: 11830984. DOI: 10.1182/blood.2023022736.

Analysis of the Healthy Platelet Proteome Identifies a New Form of Domain-Specific O-Fucosylation.

Houlahan C, Kong Y, Johnston B, Cielesh M, Chau T, Fenwick J Mol Cell Proteomics. 2024; 23(2):100717.

PMID: 38237698 PMC: 10879016. DOI: 10.1016/j.mcpro.2024.100717.

References

Pikman Y, Lee B, Mercher T, McDowell E, Ebert B, Gozo M . MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 2006; 3(7):e270. PMC: 1502153. DOI: 10.1371/journal.pmed.0030270. View

Ding J, Komatsu H, Wakita A, Kato-Uranishi M, Ito M, Satoh A . Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood. 2004; 103(11):4198-200. DOI: 10.1182/blood-2003-10-3471. View

Gandhi N, Mancera R . Heparin/heparan sulphate-based drugs. Drug Discov Today. 2010; 15(23-24):1058-69. DOI: 10.1016/j.drudis.2010.10.009. View

Reusswig F, Modares N, Brechtenkamp M, Wienands L, Kruger I, Behnke K . Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy. Hepatology. 2020; 74(1):411-427. PMC: 8236498. DOI: 10.1002/hep.31698. View

Xu M, Li J, Dias Neves M, Zhu G, Carrim N, Yu R . GPIbα is required for platelet-mediated hepatic thrombopoietin generation. Blood. 2018; 132(6):622-634. DOI: 10.1182/blood-2017-12-820779. View

Varki A . Sialic acids in human health and disease. Trends Mol Med. 2008; 14(8):351-60. PMC: 2553044. DOI: 10.1016/j.molmed.2008.06.002. View

Johnson B, Lowe G, Futterer J, Lordkipanidze M, MacDonald D, Simpson M . Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects. Haematologica. 2016; 101(10):1170-1179. PMC: 5046646. DOI: 10.3324/haematol.2016.146316. View

Li J, Callum J, Lin Y, Zhou Y, Zhu G, Ni H . Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage. Haematologica. 2014; 99(4):e61-3. PMC: 3971097. DOI: 10.3324/haematol.2013.102897. View

Baxter E, Scott L, Campbell P, East C, Fourouclas N, Swanton S . Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005; 365(9464):1054-61. DOI: 10.1016/S0140-6736(05)71142-9. View

10.

Poncz M, Rauova L, Cines D . The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT). Pathophysiol Haemost Thromb. 2006; 35(1-2):46-9. DOI: 10.1159/000093543. View

11.

Li F, Wilkins P, Crawley S, Weinstein J, Cummings R, McEver R . Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem. 1996; 271(6):3255-64. View

12.

Futterer J, Dalby A, Lowe G, Johnson B, Simpson M, Motwani J . Mutation in is associated with severe congenital thrombocytopenia. Blood. 2018; 132(17):1855-1858. PMC: 6238157. DOI: 10.1182/blood-2018-04-847798. View

13.

Alexander W, Viney E, Zhang J, Metcalf D, Kauppi M, Hyland C . Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene. Proc Natl Acad Sci U S A. 2006; 103(44):16442-7. PMC: 1637601. DOI: 10.1073/pnas.0607872103. View

14.

James C, Ugo V, Le Couedic J, Staerk J, Delhommeau F, Lacout C . A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005; 434(7037):1144-8. DOI: 10.1038/nature03546. View

15.

Demina E, Smutova V, Pan X, Fougerat A, Guo T, Zou C . Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages. J Am Heart Assoc. 2021; 10(4):e018756. PMC: 7955353. DOI: 10.1161/JAHA.120.018756. View

16.

McEver R . Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res. 2015; 107(3):331-9. PMC: 4592324. DOI: 10.1093/cvr/cvv154. View

17.

Greenberg J, Packham M, Cazenave J, Reimers H, Mustard J . Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest. 1975; 32(4):476-84. View

18.

Steiner M, Vancura S . Asymmetrical loss of sialic acid from membrane glycoproteins during platelet aging. Thromb Res. 1985; 40(4):465-71. DOI: 10.1016/0049-3848(85)90283-x. View

19.

Lee-Sundlov M, Stowell S, Hoffmeister K . Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells. J Thromb Haemost. 2020; 18(7):1535-1547. PMC: 7336546. DOI: 10.1111/jth.14874. View

20.

Kishore V, Eliason J, Matthew H . Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release. J Biomed Mater Res A. 2011; 96(4):682-92. PMC: 3972631. DOI: 10.1002/jbm.a.33024. View